PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesotheliomaKrisztián Homicskó, Rolf A. Stahel, Maxim Norkin et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 14